Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04024800 |
Title | Establishing the Recommended Biological Dose for AE37 Peptide Vaccine in Combination With Pembrolizumab That Will Enhance the Tumor-specific Immune Response and Demonstrate Efficacy in Patients With Advanced Triple-negative Breast Cancer (NSABP FB-14) |
Acronym | NSABP FB-14 |
Recruitment | Unknown status |
Gender | female |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Antigen Express, Inc |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Cancer Care Specialists of Central Illinois | Decatur | Illinois | 62526 | United States | Details | |
Crossroads Cancer Center | Effingham | Illinois | 62401 | United States | Details | |
Cancer Care Specialists of Central Illinois-Swansea | Swansea | Illinois | 62226 | United States | Details | |
Cleveland Clinic | Cleveland | Ohio | 44195 | United States | Details | |
Stefanie Spielman Comprehensive Cancer Center | Columbus | Ohio | 43212 | United States | Details | |
West Virginia University | Morgantown | West Virginia | 26506 | United States | Details |